Concepedia

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

C. W. Francis, Craig M. Kessler, Samuel Z. Goldhaber, M.J. Kovacs, Manuel Monréal, Menno V. Huisman, D. Bergqvist, Alexander G.G. Turpie, Thomas L. Ortel, Alex C. Spyropoulos,

Journal of Thrombosis and Haemostasis · 2015 · 241 citations · 11 references

DOIFull text

Open access

Concepts

References

11

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

, , +15

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Agnes Lee, Mark N. Levine, Ross Baker et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

, , +17

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis

Paolo Prandoni, Anthonie W.A. Lensing, Andrea Piccioli et al. · Blood · 2002 · 1.9K citations · Full text

, , +16

Prognosis of Cancers Associated with Venous Thromboembolism

Henrik Toft Sørensen, Lene Mellemkjær, Jørgen H. Olsen et al. · New England Journal of Medicine · 2000 · 1.6K citations · Full text

, , +12

Executive Summary

Gordon Guyatt, Elie A. Akl, Mark Crowther et al. · CHEST Journal · 2012 · 1.5K citations · Full text

, , +16